ArticleVaccines2023

Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib.

Andrea Abbona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.